Company / Return on Equity (ROE)
VIEMED HEALTHCARE, INC. Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
7.2%
FY2025
5-year range
4.7% / 38.6%
FY2021-FY2025
Trend
+52.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) returned to growth in FY2025 after 3 years of decline, reaching 7.2%.
Based on SEC 10-K filings.
7.2% in FY2025 with a 5-year CAGR of -12.3%.
Improved from 6.4% to 7.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -2.4pp
- 5-Year Change
- -12.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 52.7% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 7.2% | +52.7% |
| FY2024 | 4.7% | -26.1% |
| FY2023 | 6.4% | -33.4% |
| FY2022 | 9.6% | -75.1% |
| FY2021 | 38.6% | +97.8% |
| FY2020 | 19.5% | -33.2% |
| FY2019 | 29.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026